|
According to the reporter, during an open liver resection, there was a malformation at the staple line and it was incomplete at the central part.The jaws of the device locked on tissue but was removed strongly.The reload was also difficult to unload so a new device was used to resolve the issue and complete the case.There was no patient injury.
|
|
Evaluation summary: medtronic conducted an investigation based upon all information received.The device was available for evaluation.Visual inspection noted damage to the knife blade, consistent to application over an obstruction.For functional testing, the knife blade and cam bars were reset.The approximating lever opened fully and the single use loading unit (sulu) unloaded and loaded repeatedly without difficulty.The instrument and sulu were applied to test media and subjected to a tissue capacity/clamp test with acceptable results; the pushers advanced, the knife cut completely and cleanly, despite the noted knife blade damage.The jaws were opened.It was reported that staples were missing from the staple line after firing and did not form as expected.The reported issue were confirmed.The product analysis noted evidence that the device was not used as intended.It was also reported that the device was difficult to unload and the jaws of the device remained closed on tissue after firing.The reported issue could not be confirmed.The most likely cause could not be established from the information available.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.The instructions included with this device provide the following guidance: when positioning the instrument on the application site, ensure that no obstructions, such as previously fired staples or clips, are incorporated into the instrument jaws.Firing over an obstruction may result in incomplete cutting action and/or improperly formed staples.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|